Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban-sotorasib pharmacokinetic interaction study in healthy volunteers
NL-OMON60700Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rivaroxaban and sotorasib, sponsored by Radboud University Medical Center. Primary endpoints: Geometric mean ratio of rivaroxaban AUC and Geometric mean ratio of rivaroxaban Cmax. Started Nov 2023; status: completed.
02
Drugs
rivaroxabansotorasib
Beyond the preview
Go deeper on NL-OMON60700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60700.